VF
APVO icon

Virtu Financial’s Aptevo Therapeutics APVO Stock Holding History

Virtu Financial’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,127
Closed -$56K – 1628
2025
Q3 		$56K Buy
+2,127
New +$85.4K ﹤0.01% 1116
2025
Q1 		– Sell
-60
Closed -$93K – 1331
2024
Q4 		$93K Buy
60
+57
+1,900% +$164K ﹤0.01% 1036
2024
Q3 		$8K Buy
3
+2
+200% +$9.21K ﹤0.01% 1217
2024
Q2 		$5K Buy
+1
New +$14.9K ﹤0.01% 1179
2022
Q4 		– Hold
0
– -$86K – 1574
2022
Q3 		– Hold
0
– – – 1117
2022
Q2 		– Hold
0
– – – 1143
2019
Q4 		– Hold
0
– – – 1354
2019
Q3 		– Hold
0
– -$78K – 1410
2019
Q2 		– Hold
0
– – – 1172
2018
Q1 		– Hold
0
– -$690K – 1924
2017
Q4 		– Hold
0
– – – 629

Other funds holding APVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
TCM
Tradewinds Capital Management Bellingham, Washington $563M AUM 41.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Virtu Financial's APVO Position: Q4 2025 in Review

Virtu Financial sold out of Aptevo Therapeutics (APVO) in Q4 2025, closing a stake of 2,127 shares — an estimated $56K sold.

Virtu Financial first reported a position in APVO in Q2 2024 and held it in 4 quarters. The position peaked at $93K in Q4 2024. 11 funds tracked by Wall St. Rank hold APVO as of Q4 2025.

  • Virtu Financial reported no remaining Aptevo Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 2,127 Aptevo Therapeutics shares in Q4 2025, an estimated $56K.
  • Virtu Financial first reported a position in Aptevo Therapeutics in Q2 2024 and held it in 4 quarters.
  • Virtu Financial's Aptevo Therapeutics position peaked at $93K in Q4 2024.
  • 11 funds tracked by Wall St. Rank held Aptevo Therapeutics as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.